TEAM MEMBERS

Principal Investigator

Dr. Mark G. Swain, MD, MSc, FRCPC

Dr. Mark Swain, is a professor in the Department of Medicine at the Cumming School of Medicine, former head of the Division of Gastroenterology and Hepatology, holds the Cal Wenzel Family Foundation Chair in Hepatology, is a founding member of the Calgary Liver Unit.

Co-Investigator

Dr. Carla Coffin, MD, MSc, FRCPC

Dr. Carla Coffin, a clinician-scientist and Full Professor in Hepatology, is an internationally recognized expert in hepatitis B (HBV) and hepatitis Delta. Dr. Coffin has served on expert panels for WHO, CDC, and international HBV coalitions and played a foundational role in establishing the Canadian Hepatitis B Research Network, enabling unique, well-characterized national longitudinal cohorts and bio-repositories for HBV and HDV. At the University of Calgary, she leads a multidisciplinary team investigating HBV pathogenesis and therapies using the woodchuck hepatitis virus model.

Co-Investigator

Dr. Jenny Godley, PhD

Dr. Jenny Godley, PhD is a Professor in the Department of Department of Anthropology and Archaeology and an Adjunct Professor in the Department of Community Health Sciences at the University of Calgary. She is also the Associate Dean in Transdisciplinary Scholarship. With extensive training in demography and social network analysis, Dr. Godley has conducted quantitative research on the social determinants of health for over twenty years.

Co-Investigator

Dr. Turin Chowdhury, PhD

Dr. Turin Chowdhury is a Health Services Researcher with a focus on Immigrant and Refugee Health. Dr. Turin's primary research interest is improving access to primary care by the vulnerable population of the society, including new immigrants and refugees.

Co-Investigator

Dr. Mayur Brahmania, MD, MPH, FRCPC

Dr. Mayur Brahmania is a Hepatologist at the University of Calgary. Dr. Brahmania’s research interests include quality improvement initiatives to advance and standardize quality of care in patients living with liver disease.

Co-Investigator

Dr. Rachel Talavlikar, MD

Dr. Rachel Talavlikar is a primary care physician dedicated to providing equitable, high quality care for marginalized populations including refugees and immigrants.

Co-Investigator

Dr. Henry Nguyen, MD, FRCPC

Dr. Henry H. Nguyen is a hepatologist and clinician-scientist based in Calgary, Canada. He is an Associate Professor of Medicine at the University of Calgary and a physician in the Calgary Liver Unit.

His research focuses on the interaction between metabolism, the gut microbiome, and immune responses in liver disease. He is also involved in clinical trials evaluating emerging therapies for chronic liver diseases.

Outside of his academic and clinical roles, Dr. Nguyen founded Liver Health Connect, a community initiative that provides culturally tailored liver health education and outreach. This operates independently from his research program

Clinical Research Manager

Pam Crotty

Info to be added.

Project Lead

Folake Arinde

Info to be added.

Research Coordinator

Irfan Hyder, MA

Irfan is a policy and program professional who blends community-driven research, stakeholder collaboration, and data-driven strategies to design equitable social initiatives and culturally responsive solutions. His expertise is in policy analysis and program management.